Cardiovascular Systems

Selected news for the company - Cardiovascular Systems, collected since 10/2017. This company shares news with Zacks Investment Research, Tactile Systems Technology, Medtronic, Zimmer Biomet and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/13/2021 Deutsche Bank AG Boosts Position in Cardiovascular Systems, Inc. (NASDAQ:CSII) - Transcript Daily transcriptdaily.com Deutsche Bank AG increased its holdings in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) by 94.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 61,028 shares of the medical device company’s stock after purchasing an additional 29,674 shares during the quarter. Deutsche Bank AG owned approximately 0.15% of Cardiovascular Systems worth $2,603,000 at the ...
10/12/2021 The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga ... Food and Drug Administration regarding approval of breast cancer drug) - Axcella Health Inc. (NASDAQ: [AXLA] ) - Aytu Biopharma, Inc. (NASDAQ: [AYTU] ) - BiondVax Pharmaceuticals Ltd. (NASDAQ: [BVXV] ) - BioSig Technologies, Inc. (NASDAQ: [BSGM] ) - BioVie Inc. (NASDAQ: [BIVI] ) - Cardiovascular Systems , Inc. (NASDAQ: [CSII] ) - Centessa Pharmaceuticals Limited (NASDAQ: [CNTA] ) - Century Therapeutics, Inc. (NASDAQ: [IPSC] ) - Chemomab Therapeutics Ltd. (NASDAQ: [CMMB] ) - DICE Therapeutics, Inc. (NASDAQ: [DICE] ) - Diffusion Pharmaceuticals Inc. (NASDAQ: [DFFN] ) - Eliem Therapeutics, Inc. (NASDAQ: [ELYM] ) - Exscientia ...
10/9/2021 Terumo (OTCMKTS:TRUMY) Upgraded to “Hold” by Zacks Investment Research - Transcript Daily transcriptdaily.com ... Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo’s Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer ...
10/6/2021 The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal | Markets Insider Business Insider ... Inc. (NASDAQ: AXLA ) BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV ) BioSig Technologies, Inc. (NASDAQ: BSGM ) BioVie Inc. (NASDAQ: BIVI ) Black Diamond Therapeutics, Inc. (NASDAQ: BDTX ) Burning Rock Biotech Limited (NASDAQ: BNR ) Caladrius Biosciences, Inc. (NASDAQ: CLBS ) Cardiovascular Systems , Inc. (NASDAQ: CSII ) Centessa Pharmaceuticals Limited (NASDAQ: CNTA ) Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX ) Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI ) Chemomab Therapeutics Ltd. (NASDAQ: CMMB ) Concert Pharmaceuticals, Inc. (NASDAQ: CNCE ) Cue Health Inc. (NASDAQ: HLTH ) (IPOed ...
10/5/2021 Citigroup Inc. Increases Stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) - The Cerbat Gem thecerbatgem.com Citigroup Inc. boosted its position in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) by 171.9% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 39,329 shares of the medical device company’s stock after purchasing an additional 24,867 shares during the period. Citigroup Inc.’s holdings in Cardiovascular Systems were worth $1,677,000 as of its most recent SEC filing.A number of other hedge funds have also recently made changes ...
10/5/2021 Condor Gold (LON:CNR) Shares Pass Below 50 Day Moving Average of $41.68 | Daily Political Daily Political Sigyn Therapeutics ( NASDAQ:SIGY ) and Cardiovascular Systems ( NASDAQ:CSII ) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation. Profitability This table compares Sigyn Therapeutics and Cardiovascular Systems ’ net margins, return on equity and return on assets. Institutional & Insider Ownership 94.3% of Cardiovascular Systems shares ...
10/5/2021 Head-To-Head Review: Cardiovascular Systems (NASDAQ:CSII) and Sigyn Therapeutics (NASDAQ:SIGY) zolmax.com ... medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations. Profitability This table compares Cardiovascular Systems and Sigyn Therapeutics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Cardiovascular Systems -5.18% -4.95% -3.86% Sigyn Therapeutics N/A N/A -190.58% 94.3 ...
10/5/2021 Citigroup Inc. Buys 24,867 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) American Banking News Citigroup Inc. boosted its stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) by 171.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,329 shares of the medical device company’s stock after acquiring an additional 24,867 shares during the period. Citigroup Inc. owned 0.10% of Cardiovascular Systems worth $1,677,000 as of its most recent filing with the SEC.Other hedge ...
10/5/2021 The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga ... Inc. (NASDAQ: [AVRO] ) - Aziyo Biologics, Inc. (NASDAQ: [AZYO] ) - BiondVax Pharmaceuticals Ltd. (NASDAQ: [BVXV] ) - BioSig Technologies, Inc. (NASDAQ: [BSGM] ) - BioVie Inc. (NASDAQ: [BIVI] ) - Black Diamond Therapeutics, Inc. (NASDAQ: [BDTX] ) - Burning Rock Biotech Limited (NASDAQ: [BNR] ) - Cardiovascular Systems , Inc. (NASDAQ: [CSII] ) - Centessa Pharmaceuticals Limited (NASDAQ: [CNTA] ) - Checkmate Pharmaceuticals, Inc. (NASDAQ: [CMPI] ) - Chemomab Therapeutics Ltd. (NASDAQ: [CMMB] ) - China SXT Pharmaceuticals, Inc. (NASDAQ: [SXTC] ) - Clarus Therapeutics Holdings, Inc. (NASDAQ: [CRXT] ) - Cue Health Inc. (NASDAQ ...
9/28/2021 Q1 2022 Earnings Estimate for Cardiovascular Systems, Inc. Issued By Oppenheimer (NASDAQ:CSII) rivertonroll.com Cardiovascular Systems, Inc. (NASDAQ:CSII) – Oppenheimer upped their Q1 2022 EPS estimates for shares of Cardiovascular Systems in a research note issued to investors on Thursday, September 23rd. Oppenheimer analyst S. Kalia now expects that the medical device company will post earnings per share of ($0.05) for the quarter, up from their previous estimate of ($0.06). Other equities analysts also recently issued research reports about the stock. Northland Securities ...
9/27/2021 orth America Interventional Cardiology and Peripheral Vascular Devices Market Impressive Gains Including Top Key Players Biosensors International Group, Ltd., W. L. Gore & Associates, Inc., Teleflex Incorporated., REX MEDICAL., ORBUSNEICH MEDICAL., Merit Medical Systems, Getinge AB., JOTEC GmbH, Cook, Bolton Medical packagingnews24.com ... minimizing the risk of failure. Some of the key players profiled in the study are, Medtronic, Terumo Corporation, BD, B. Braun Melsungen AG, Cardinal Health., Abbott., Boston Scientific Corporation, Q3 Medical Devices Limited and Cardiovascular Systems , Inc. among others. The surge in the elderly population has driven the need for interventional cardiology. It is a cardiology subspecialty that uses intravascular catheter-based fluoroscopy techniques to heal coronary artery, tube and ...
9/26/2021 Leerink Partners Thinks Cardiovascular Systems’ Stock is Going to Recover analystratings.com Leerink Partners Thinks Cardiovascular Systems’ Stock is Going to Recover [Carrie Williams] Leerink Partners analyst Danielle Antalffy maintained a Buy rating on Cardiovascular Systems ( CSII – Research Report ) on September 22. The company’s shares closed last Friday at $33.34, close to its 52-week low of $32.52. According to TipRanks.com , Antalffy is a 5-star analyst with an average return of 19.9% and a 61.6% success rate. Antalffy ...
9/26/2021 Analysts’ Updated EPS Estimates for September, 26th (AMRN, BA, BLU, CRM, CSII, GRTX, HAL, HCAT, KIM, LNTH) American Banking News Analysts’ updated eps estimates for Sunday, September 26th:Amarin (NASDAQ:AMRN) had its buy rating reaffirmed by analysts at SVB Leerink LLC. The firm currently has a $12.00 price target on the stock.The Boeing (NYSE:BA) had its hold rating reissued by analysts at Wells Fargo & Company.salesforce.com (NYSE:CRM) had its buy rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $315.00 price ...
9/25/2021 Needham & Company LLC Lowers Cardiovascular Systems (NASDAQ:CSII) Price Target to $49.00 - Transcript Daily transcriptdaily.com ... Äôs price objective suggests a potential upside of 46.97% from the stock‚Äôs current price.A number of other research firms have also commented on CSII. SVB Leerink set a $38.75 price target on Cardiovascular Systems and gave the company a ‚Äúbuy‚Äù rating in a research report on Friday, July 23rd. Northland Securities reaffirmed a ‚Äúbuy‚Äù rating and set a $45.00 price target on shares of Cardiovascular Systems ...
9/25/2021 Cardiovascular Systems (NASDAQ:CSII) PT Lowered to $49.00 - Stock Observer thestockobserver.com ... price would suggest a potential upside of 46.97% from the stock’s current price.A number of other research analysts have also weighed in on CSII. SVB Leerink set a $38.75 price objective on Cardiovascular Systems and gave the company a “buy” rating in a research report on Friday, July 23rd. Northland Securities reiterated a “buy” rating and issued a $45.00 price target on shares of Cardiovascular Systems ...
9/25/2021 -$0.10 Earnings Per Share Expected for Cardiovascular Systems, Inc. (NASDAQ:CSII) This Quarter - Stock Observer thestockobserver.com Analysts predict that Cardiovascular Systems, Inc. (NASDAQ:CSII) will post ($0.10) earnings per share (EPS) for the current quarter, Zacks reports. Six analysts have made estimates for Cardiovascular Systems’ earnings. The lowest EPS estimate is ($0.15) and the highest is ($0.05). Cardiovascular Systems reported earnings per share of ($0.05) during the same quarter last year, which suggests a negative year-over-year growth rate of 100%. The company is ...
9/25/2021 Cardiovascular Systems, Inc. (NASDAQ:CSII) Expected to Post Earnings of -$0.10 Per Share modernreaders.com Analysts predict that Cardiovascular Systems , Inc. (NASDAQ:CSII) will post earnings of ($0.10) per share for the current quarter, according to Zacks Investment Research . Six analysts have made estimates for Cardiovascular Systems ’ earnings, with estimates ranging from ($0.15) to ($0.05). Cardiovascular Systems posted earnings of ($0.05) per share during the same quarter last year, which would suggest a negative year over year growth rate of 100%. The firm is ...
9/24/2021 Extracorporeal Membrane Oxygenation Machine Market Research Methodology, Size, Share, Trends, Business Statistics, Top Key Players, Gross Margin and Forecast to 2031 delhi-today.com ... pandemic, speculation patterns, organization profiles, benefit, etc The major manufacturers covered in this report: MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Medtronic plc, Microport Scientific Corporation, Nipro Medical Corporation, Sorin Group, and Terumo Cardiovascular Systems Corporation. Market Segmentation as below: By Component:pumps, oxygenators, controllers, cannula, and accessories By Modality type:veno-arterial, veno-venous, and others By Application:respiratory, cardiac, extracorporeal cardiopulmonary resuscitation (ECPR), and others By Patient ...
9/23/2021 The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data Benzinga ... Corporation (NYSE: [RGEN] ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 22) - Ambrx Biopharma Inc. (NYSE: [AMAM] ) - Absci Corporation (NASDAQ: [ABSI] ) - Acutus Medical, Inc. (NASDAQ: [AFIB] ) - Alzamend Neuro, Inc. (NASDAQ: [ALZN] ) - Cardiovascular Systems , Inc. (NASDAQ: [CSII] ) (preannounced revenue shortfall) - Centessa Pharmaceuticals Limited (NASDAQ: [CNTA] ) - Cullinan Oncology, Inc. (NASDAQ: [CGEM] ) - FibroGen, Inc. (NASDAQ: [FGEN] ) (reacted to negative analyst action) - Frequency Therapeutics, Inc. (NASDAQ: [FREQ] ) (announced new data from ...
9/23/2021 The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data | Markets Insider Business Insider ... Corporation (NYSE: RGEN ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 22)Ambrx Biopharma Inc. (NYSE: AMAM ) Absci Corporation (NASDAQ: ABSI ) Acutus Medical, Inc. (NASDAQ: AFIB ) Alzamend Neuro, Inc. (NASDAQ: ALZN ) Cardiovascular Systems , Inc. (NASDAQ: CSII ) (preannounced revenue shortfall) Centessa Pharmaceuticals Limited (NASDAQ: CNTA ) Cullinan Oncology, Inc. (NASDAQ: CGEM ) FibroGen, Inc. (NASDAQ: FGEN ) (reacted to negative analyst action) Frequency Therapeutics, Inc. (NASDAQ: FREQ ) (announced new data from ...